Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus

Archive ouverte

Achard, Carole | Boisgerault, Nicolas | Delaunay, Tiphaine | Tangy, Frédéric | Grégoire, Marc | Fonteneau, Jean-François

Edité par CCSD ; OMICS Publishing Group -

International audience. Antitumor virotherapy is a developing approach to treat cancer with oncolytic viruses, namely replicative viruses that exclusively or preferentially infect and kill tumor cells. Attenuated strains of Measles Virus (MV) are now being used as oncolytic viruses in clinical trials to treat several types of cancer. The efficacy of oncolytic viruses is mainly due to their capacity to infect and kill tumor cells, but it has also been demonstrated that their capacity to induce immunogenic cell death can activate an antitumor immune response. In this review, we describe the oncolytic capacity of MV and the concept of Immunogenic Cell Death (ICD). We then review how MV induces immunogenic cell death, which can be beneficial for cancer treatment.

Suggestions

Du même auteur

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus

Archive ouverte | Delaunay, Tiphaine | CCSD

International audience

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus. Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus: Interferon genes loss sensitizes tumor cells to viral lysis

Archive ouverte | Delaunay, Tiphaine | CCSD

International audience. Oncolytic immunotherapy is based on the use of non-pathogenic replicative oncolytic viruses (OV) that infect and kill exclusively tumor cells. Recently, we showed that the spontaneous oncolyt...

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response

Archive ouverte | Achard, Carole | CCSD

International audience. Attenuated measles virus (MV) is currently being evaluated as an oncolytic virus in clinical trials and could represent a new therapeutic approach for malignant pleural mesothelioma (MPM). He...

Chargement des enrichissements...